Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most aggressive intracranial tumor which can be divided into two subtypes based on status of isocitrate dehydrogenase (IDH). A small fraction of patients after receiving standard treatment can be long-term survivors (LTS). This study was designed to disclose the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Jiang, Haihui, Yu, Kefu, Cui, Yong, Ren, Xiaohui, Li, Mingxiao, Zhang, Guobin, Yang, Chuanwei, Zhao, Xuzhe, Zhu, Qinghui, Lin, Song
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8155513/
https://ncbi.nlm.nih.gov/pubmed/34055603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.632663
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados